Industry Research Reports

Home > Reports > Medical Devices & Consumables > Cardiopulmonary Support System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Cardiopulmonary Support System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published Date: 2026-01-19

Pages: 85 Pages

Report ld: 5777921

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Cardiopulmonary Support System Market Size(US$)

CAGR 2026-2032

2.5%

Market Size,2032

USD 168

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 145 million

Market Forecast in 2032(Value)

US$ 168 million

CAGR

2.5%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Cardiopulmonary Support System was estimated to be worth US$ 141 million in 2025 and is projected to reach US$ 168 million, growing at a CAGR of 2.5% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Cardiopulmonary Support System cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

A cardiopulmonary support system is an integrated set of medical devices and technologies designed to temporarily replace or assist the function of the heart and lungs to ensure that blood is adequately oxygenated and pumped to various organs throughout the body to maintain a patient's vital signs.

The North American market for Cardiopulmonary Support System was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Cardiopulmonary Support System was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Cardiopulmonary Support System was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Cardiopulmonary Support System market include Johnson & Johnson, Getinge, Abbott, Fresenius Medical Care, Xenios AG, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Cardiopulmonary Support System, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Cardiopulmonary Support System market size, estimations, and forecasts are presented in terms of sales volume (Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Support System.

MARKET SEGMENTATION

By Company

Johnson & Johnson
Getinge
Abbott
Fresenius Medical Care
Xenios AG

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Portable
Vertical

Segment by Application

Care Department
Emergency Department
Pediatric Department
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Cardiopulmonary Support System manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Cardiopulmonary Support System sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Cardiopulmonary Support System sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Cardiopulmonary Support System Product Introduction

1.2 Global Cardiopulmonary Support System Market Size Forecast

1.2.1 Global Cardiopulmonary Support System Sales Value (2021–2032)

1.2.2 Global Cardiopulmonary Support System Sales Volume (2021–2032)

1.2.3 Global Cardiopulmonary Support System Sales Price (2021–2032)

1.3 Cardiopulmonary Support System Market Trends & Drivers

1.3.1 Cardiopulmonary Support System Industry Trends

1.3.2 Cardiopulmonary Support System Market Drivers & Opportunities

1.3.3 Cardiopulmonary Support System Market Challenges

1.3.4 Cardiopulmonary Support System Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Cardiopulmonary Support System Players Revenue Ranking (2025)

2.2 Global Cardiopulmonary Support System Revenue by Company (2021–2026)

2.3 Global Cardiopulmonary Support System Sales Volume Ranking of Players (2025)

2.4 Global Cardiopulmonary Support System Sales Volume by Company (2021–2026)

2.5 Global Cardiopulmonary Support System Average Price by Company (2021–2026)

2.6 Key Manufacturers Cardiopulmonary Support System Manufacturing Base and Headquarters

2.7 Key Manufacturers Cardiopulmonary Support System Product Offerings

2.8 Key Manufacturers Start of Mass Production of Cardiopulmonary Support System

2.9 Cardiopulmonary Support System Market Competitive Analysis

2.9.1 Cardiopulmonary Support System Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Cardiopulmonary Support System Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cardiopulmonary Support System revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Cardiopulmonary Support System Market Classification

3.1 Introduction by Type

3.1.1 Portable

3.1.2 Vertical

3.1.3 Global Cardiopulmonary Support System Sales Value by Type

3.1.3.1 Global Cardiopulmonary Support System Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Cardiopulmonary Support System Sales Value, by Type (2021–2032)

3.1.3.3 Global Cardiopulmonary Support System Sales Value, by Type (%), 2021–2032

3.1.4 Global Cardiopulmonary Support System Sales Volume by Type

3.1.4.1 Global Cardiopulmonary Support System Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Cardiopulmonary Support System Sales Volume, by Type (2021–2032)

3.1.4.3 Global Cardiopulmonary Support System Sales Volume, by Type (%), 2021–2032

3.1.5 Global Cardiopulmonary Support System Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Care Department

4.1.2 Emergency Department

4.1.3 Pediatric Department

4.1.4 Others

4.2 Global Cardiopulmonary Support System Sales Value by Application

4.2.1 Global Cardiopulmonary Support System Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Cardiopulmonary Support System Sales Value, by Application (2021–2032)

4.2.3 Global Cardiopulmonary Support System Sales Value, by Application (%), 2021–2032

4.3 Global Cardiopulmonary Support System Sales Volume by Application

4.3.1 Global Cardiopulmonary Support System Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Cardiopulmonary Support System Sales Volume, by Application (2021–2032)

4.3.3 Global Cardiopulmonary Support System Sales Volume, by Application (%), 2021–2032

4.4 Global Cardiopulmonary Support System Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Cardiopulmonary Support System Sales Value by Region

5.1.1 Global Cardiopulmonary Support System Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Cardiopulmonary Support System Sales Value by Region (2021–2026)

5.1.3 Global Cardiopulmonary Support System Sales Value by Region (2027–2032)

5.1.4 Global Cardiopulmonary Support System Sales Value by Region (%), 2021–2032

5.2 Global Cardiopulmonary Support System Sales Volume by Region

5.2.1 Global Cardiopulmonary Support System Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Cardiopulmonary Support System Sales Volume by Region (2021–2026)

5.2.3 Global Cardiopulmonary Support System Sales Volume by Region (2027–2032)

5.2.4 Global Cardiopulmonary Support System Sales Volume by Region (%), 2021–2032

5.3 Global Cardiopulmonary Support System Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Cardiopulmonary Support System Sales Value, 2021–2032

5.4.2 North America Cardiopulmonary Support System Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Cardiopulmonary Support System Sales Value, 2021–2032

5.5.2 Europe Cardiopulmonary Support System Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Cardiopulmonary Support System Sales Value, 2021–2032

5.6.2 Asia Pacific Cardiopulmonary Support System Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Cardiopulmonary Support System Sales Value, 2021–2032

5.7.2 South America Cardiopulmonary Support System Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Cardiopulmonary Support System Sales Value, 2021–2032

5.8.2 Middle East & Africa Cardiopulmonary Support System Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Cardiopulmonary Support System Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Cardiopulmonary Support System Sales Value and Sales Volume

6.2.1 Key Countries/Regions Cardiopulmonary Support System Sales Value, 2021–2032

6.2.2 Key Countries/Regions Cardiopulmonary Support System Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Cardiopulmonary Support System Sales Value, 2021–2032

6.3.2 United States Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Cardiopulmonary Support System Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Cardiopulmonary Support System Sales Value, 2021–2032

6.4.2 Europe Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Cardiopulmonary Support System Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Cardiopulmonary Support System Sales Value, 2021–2032

6.5.2 China Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

6.5.3 China Cardiopulmonary Support System Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Cardiopulmonary Support System Sales Value, 2021–2032

6.6.2 Japan Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Cardiopulmonary Support System Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Cardiopulmonary Support System Sales Value, 2021–2032

6.7.2 South Korea Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Cardiopulmonary Support System Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Cardiopulmonary Support System Sales Value, 2021–2032

6.8.2 Southeast Asia Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Cardiopulmonary Support System Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Cardiopulmonary Support System Sales Value, 2021–2032

6.9.2 India Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

6.9.3 India Cardiopulmonary Support System Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Johnson & Johnson

7.1.1 Johnson & Johnson Company Information

7.1.2 Johnson & Johnson Introduction and Business Overview

7.1.3 Johnson & Johnson Cardiopulmonary Support System Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Johnson & Johnson Cardiopulmonary Support System Product Offerings

7.1.5 Johnson & Johnson Recent Developments

7.2 Getinge

7.2.1 Getinge Company Information

7.2.2 Getinge Introduction and Business Overview

7.2.3 Getinge Cardiopulmonary Support System Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Getinge Cardiopulmonary Support System Product Offerings

7.2.5 Getinge Recent Developments

7.3 Abbott

7.3.1 Abbott Company Information

7.3.2 Abbott Introduction and Business Overview

7.3.3 Abbott Cardiopulmonary Support System Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Abbott Cardiopulmonary Support System Product Offerings

7.3.5 Abbott Recent Developments

7.4 Fresenius Medical Care

7.4.1 Fresenius Medical Care Company Information

7.4.2 Fresenius Medical Care Introduction and Business Overview

7.4.3 Fresenius Medical Care Cardiopulmonary Support System Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Fresenius Medical Care Cardiopulmonary Support System Product Offerings

7.4.5 Fresenius Medical Care Recent Developments

7.5 Xenios AG

7.5.1 Xenios AG Company Information

7.5.2 Xenios AG Introduction and Business Overview

7.5.3 Xenios AG Cardiopulmonary Support System Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 Xenios AG Cardiopulmonary Support System Product Offerings

7.5.5 Xenios AG Recent Developments

8 Industry Chain Analysis

8.1 Cardiopulmonary Support System Industrial Chain

8.2 Cardiopulmonary Support System Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Cardiopulmonary Support System Sales Model

8.5.2 Sales Channels

8.5.3 Cardiopulmonary Support System Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Cardiopulmonary Support System Market Trends

Table 2. Cardiopulmonary Support System Market Drivers & Opportunities

Table 3. Cardiopulmonary Support System Market Challenges

Table 4. Cardiopulmonary Support System Market Restraints

Table 5. Global Cardiopulmonary Support System Revenue by Company (US$ Million), 2021–2026

Table 6. Global Cardiopulmonary Support System Revenue Market Share by Company (2021–2026)

Table 7. Global Cardiopulmonary Support System Sales Volume by Company (Units), 2021–2026

Table 8. Global Cardiopulmonary Support System Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Cardiopulmonary Support System Price by Company (US$/Unit), 2021–2026

Table 10. Key Manufacturers Cardiopulmonary Support System Manufacturing Base and Headquarters

Table 11. Key Manufacturers Cardiopulmonary Support System Product Type

Table 12. Key Manufacturers Start of Mass Production of Cardiopulmonary Support System

Table 13. Global Cardiopulmonary Support System Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Cardiopulmonary Support System revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Cardiopulmonary Support System Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Cardiopulmonary Support System Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Cardiopulmonary Support System Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Cardiopulmonary Support System Sales Market Share in Value by Type (2021–2026)

Table 20. Global Cardiopulmonary Support System Sales Market Share in Value by Type (2027–2032)

Table 21. Global Cardiopulmonary Support System Sales Volume by Type: 2021 vs 2025 vs 2032 (Units)

Table 22. Global Cardiopulmonary Support System Sales Volume by Type (Units), 2021–2026

Table 23. Global Cardiopulmonary Support System Sales Volume by Type (Units), 2027–2032

Table 24. Global Cardiopulmonary Support System Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Cardiopulmonary Support System Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Cardiopulmonary Support System Price by Type (US$/Unit), 2021–2026

Table 27. Global Cardiopulmonary Support System Price by Type (US$/Unit), 2027–2032

Table 28. Global Cardiopulmonary Support System Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Cardiopulmonary Support System Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Cardiopulmonary Support System Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Cardiopulmonary Support System Sales Market Share in Value by Application (2021–2026)

Table 32. Global Cardiopulmonary Support System Sales Market Share in Value by Application (2027–2032)

Table 33. Global Cardiopulmonary Support System Sales Volume by Application: 2021 vs 2025 vs 2032 (Units)

Table 34. Global Cardiopulmonary Support System Sales Volume by Application (Units), 2021–2026

Table 35. Global Cardiopulmonary Support System Sales Volume by Application (Units), 2027–2032

Table 36. Global Cardiopulmonary Support System Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Cardiopulmonary Support System Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Cardiopulmonary Support System Price by Application (US$/Unit), 2021–2026

Table 39. Global Cardiopulmonary Support System Price by Application (US$/Unit), 2027–2032

Table 40. Global Cardiopulmonary Support System Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Cardiopulmonary Support System Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Cardiopulmonary Support System Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Cardiopulmonary Support System Sales Value by Region (%), 2021–2026

Table 44. Global Cardiopulmonary Support System Sales Value by Region (%), 2027–2032

Table 45. Global Cardiopulmonary Support System Sales Volume by Region (Units): 2021 vs 2025 vs 2032

Table 46. Global Cardiopulmonary Support System Sales Volume by Region (Units), 2021–2026

Table 47. Global Cardiopulmonary Support System Sales Volume by Region (Units), 2027–2032

Table 48. Global Cardiopulmonary Support System Sales Volume by Region (%), 2021–2026

Table 49. Global Cardiopulmonary Support System Sales Volume by Region (%), 2027–2032

Table 50. Global Cardiopulmonary Support System Average Price by Region (US$/Unit), 2021–2026

Table 51. Global Cardiopulmonary Support System Average Price by Region (US$/Unit), 2027–2032

Table 52. Key Countries/Regions Cardiopulmonary Support System Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Cardiopulmonary Support System Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Cardiopulmonary Support System Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Cardiopulmonary Support System Sales Volume, (Units), 2021–2026

Table 56. Key Countries/Regions Cardiopulmonary Support System Sales Volume, (Units), 2027–2032

Table 57. Johnson & Johnson Company Information

Table 58. Johnson & Johnson Introduction and Business Overview

Table 59. Johnson & Johnson Cardiopulmonary Support System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 60. Johnson & Johnson Cardiopulmonary Support System Product Offerings

Table 61. Johnson & Johnson Recent Developments

Table 62. Getinge Company Information

Table 63. Getinge Introduction and Business Overview

Table 64. Getinge Cardiopulmonary Support System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 65. Getinge Cardiopulmonary Support System Product Offerings

Table 66. Getinge Recent Developments

Table 67. Abbott Company Information

Table 68. Abbott Introduction and Business Overview

Table 69. Abbott Cardiopulmonary Support System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 70. Abbott Cardiopulmonary Support System Product Offerings

Table 71. Abbott Recent Developments

Table 72. Fresenius Medical Care Company Information

Table 73. Fresenius Medical Care Introduction and Business Overview

Table 74. Fresenius Medical Care Cardiopulmonary Support System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 75. Fresenius Medical Care Cardiopulmonary Support System Product Offerings

Table 76. Fresenius Medical Care Recent Developments

Table 77. Xenios AG Company Information

Table 78. Xenios AG Introduction and Business Overview

Table 79. Xenios AG Cardiopulmonary Support System Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)

Table 80. Xenios AG Cardiopulmonary Support System Product Offerings

Table 81. Xenios AG Recent Developments

Table 82. Key Raw Materials Lists

Table 83. Key Suppliers of Raw Materials Lists

Table 84. Cardiopulmonary Support System Downstream Customers

Table 85. Cardiopulmonary Support System Distributors List

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Cardiopulmonary Support System Product Picture

Figure 2. Global Cardiopulmonary Support System Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 4. Global Cardiopulmonary Support System Sales Volume (Units), 2021–2032

Figure 5. Global Cardiopulmonary Support System Sales Price (US$/Unit), 2021–2032

Figure 6. Cardiopulmonary Support System Report Years Considered

Figure 7. Global Cardiopulmonary Support System Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Cardiopulmonary Support System Sales Volume Ranking of Players (Units), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cardiopulmonary Support System Revenue in 2025

Figure 10. Cardiopulmonary Support System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. Portable Picture

Figure 12. Vertical Picture

Figure 13. Global Cardiopulmonary Support System Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Cardiopulmonary Support System Sales Value Market Share by Type, 2025 & 2032

Figure 15. Global Cardiopulmonary Support System Sales Volume by Type (Units), 2021 vs 2025 vs 2032

Figure 16. Global Cardiopulmonary Support System Sales Volume Market Share by Type, 2025 & 2032

Figure 17. Global Cardiopulmonary Support System Price by Type (US$/Unit), 2021–2032

Figure 18. Product Picture of Care Department

Figure 19. Product Picture of Emergency Department

Figure 20. Product Picture of Pediatric Department

Figure 21. Product Picture of Others

Figure 22. Global Cardiopulmonary Support System Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Cardiopulmonary Support System Sales Value Market Share by Application, 2025 & 2032

Figure 24. Global Cardiopulmonary Support System Sales Volume by Application (Units), 2021 vs 2025 vs 2032

Figure 25. Global Cardiopulmonary Support System Sales Volume Market Share by Application, 2025 & 2032

Figure 26. Global Cardiopulmonary Support System Price by Application (US$/Unit), 2021–2032

Figure 27. North America Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 28. North America Cardiopulmonary Support System Sales Value by Country (%), 2025 vs 2032

Figure 29. Europe Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 30. Europe Cardiopulmonary Support System Sales Value by Country (%), 2025 vs 2032

Figure 31. Asia Pacific Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 32. Asia Pacific Cardiopulmonary Support System Sales Value by Region (%), 2025 vs 2032

Figure 33. South America Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 34. South America Cardiopulmonary Support System Sales Value by Country (%), 2025 vs 2032

Figure 35. Middle East & Africa Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 36. Middle East & Africa Cardiopulmonary Support System Sales Value by Country (%), 2025 vs 2032

Figure 37. Key Countries/Regions Cardiopulmonary Support System Sales Value (%), 2021–2032

Figure 38. Key Countries/Regions Cardiopulmonary Support System Sales Volume (%), 2021–2032

Figure 39. United States Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 40. United States Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

Figure 41. United States Cardiopulmonary Support System Sales Value by Application (%), 2025 vs 2032

Figure 42. Europe Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 43. Europe Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

Figure 44. Europe Cardiopulmonary Support System Sales Value by Application (%), 2025 vs 2032

Figure 45. China Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 46. China Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

Figure 47. China Cardiopulmonary Support System Sales Value by Application (%), 2025 vs 2032

Figure 48. Japan Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 49. Japan Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

Figure 50. Japan Cardiopulmonary Support System Sales Value by Application (%), 2025 vs 2032

Figure 51. South Korea Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 52. South Korea Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

Figure 53. South Korea Cardiopulmonary Support System Sales Value by Application (%), 2025 vs 2032

Figure 54. Southeast Asia Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 55. Southeast Asia Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

Figure 56. Southeast Asia Cardiopulmonary Support System Sales Value by Application (%), 2025 vs 2032

Figure 57. India Cardiopulmonary Support System Sales Value (US$ Million), 2021–2032

Figure 58. India Cardiopulmonary Support System Sales Value by Type (%), 2025 vs 2032

Figure 59. India Cardiopulmonary Support System Sales Value by Application (%), 2025 vs 2032

Figure 60. Cardiopulmonary Support System Industrial Chain

Figure 61. Cardiopulmonary Support System Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Cardiopulmonary Support System market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Cardiopulmonary Support System market is 2.5% 2026 to 2032.

What was the global market size of Cardiopulmonary Support System in 2026? shouQi

Which companies rank high in the global Cardiopulmonary Support System market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Cardiopulmonary Support System in 2032? shouQi

Related Reports

Global Cardiopulmonary Support System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cardiopulmonary Support System market is projected to grow from US$ 141 million in 2025 to US$ 168 million by 2032, at a CAGR of 2.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 121
USD 4900.00
(Single User License)
Global Cardiopulmonary Support System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cardiopulmonary Support System market size was US$ 141 million in 2025 and is forecast to reach a readjusted size of US$ 168 million by 2032 with a CAGR of 2.5% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 68
USD 4250.00
(Single User License)
Global Cardiopulmonary Support System Market Research Report 2026
The global Cardiopulmonary Support System market was valued at US$ 141 million in 2025 and is anticipated to reach US$ 168 million by 2032, at a CAGR of 2.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 97
USD 2900.00
(Single User License)
Global Cardiopulmonary Support System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cardiopulmonary Support System market size was US$ 138 million in 2024 and is forecast to a readjusted size of US$ 164 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 65
USD 4250.00
(Single User License)
Global Cardiopulmonary Support System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cardiopulmonary Support System market is projected to grow from US$ 138 million in 2024 to US$ 164 million by 2031, at a CAGR of 2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 125
USD 4900.00
(Single User License)
Cardiopulmonary Support System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cardiopulmonary Support System was estimated to be worth US$ 138 million in 2024 and is forecast to a readjusted size of US$ 164 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 82
USD 3950.00
(Single User License)
Global Cardiopulmonary Support System Market Research Report 2025
The global market for Cardiopulmonary Support System was valued at US$ 138 million in the year 2024 and is projected to reach a revised size of US$ 164 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published Date: 2025-03-10
Pages: 76
USD 2900.00
(Single User License)
Global and United States Cardiopulmonary Support System Market Report & Forecast 2024-2030
The global Cardiopulmonary Support System revenue was US$ 135 million in 2023 and is forecast to a readjusted size of US$ 160 million by 2030 with a CAGR of 2.5% during the review period (2024-2030).
Published Date: 2024-12-26
Pages: 93
USD 4350.00
(Single User License)
Global Cardiopulmonary Support System Market Insights, Forecast to 2030
Valued at US$ 138 million in 2024, the global Cardiopulmonary Support System market is forecast to reach US$ 160 million by 2030, at a CAGR of 2.5% during the forecast period.
Published Date: 2024-12-26
Pages: 122
USD 4900.00
(Single User License)
Global Cardiopulmonary Support System Market Research Report 2024
The global market for Cardiopulmonary Support System was valued at US$ 135 million in the year 2023 and is projected to reach a revised size of US$ 160 million by 2030, growing at a CAGR of 2.5% during the forecast period.
Published Date: 2024-12-26
Pages: 74
USD 2900.00
(Single User License)

Global Cardiopulmonary Support System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cardiopulmonary Support System market is projected to grow from US$ 141 million in 2025 to US$ 168 million by 2032, at a CAGR of 2.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 121
USD 4900.00 (Single User License)
Global Cardiopulmonary Support System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cardiopulmonary Support System market size was US$ 141 million in 2025 and is forecast to reach a readjusted size of US$ 168 million by 2032 with a CAGR of 2.5% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 68
USD 4250.00 (Single User License)
Global Cardiopulmonary Support System Market Research Report 2026
The global Cardiopulmonary Support System market was valued at US$ 141 million in 2025 and is anticipated to reach US$ 168 million by 2032, at a CAGR of 2.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 97
USD 2900.00 (Single User License)
Global Cardiopulmonary Support System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cardiopulmonary Support System market size was US$ 138 million in 2024 and is forecast to a readjusted size of US$ 164 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 65
USD 4250.00 (Single User License)
Global Cardiopulmonary Support System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cardiopulmonary Support System market is projected to grow from US$ 138 million in 2024 to US$ 164 million by 2031, at a CAGR of 2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 125
USD 4900.00 (Single User License)
Cardiopulmonary Support System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cardiopulmonary Support System was estimated to be worth US$ 138 million in 2024 and is forecast to a readjusted size of US$ 164 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 82
USD 3950.00 (Single User License)
Global Cardiopulmonary Support System Market Research Report 2025
The global market for Cardiopulmonary Support System was valued at US$ 138 million in the year 2024 and is projected to reach a revised size of US$ 164 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published: 2025-03-10
Pages: 76
USD 2900.00 (Single User License)
Global and United States Cardiopulmonary Support System Market Report & Forecast 2024-2030
The global Cardiopulmonary Support System revenue was US$ 135 million in 2023 and is forecast to a readjusted size of US$ 160 million by 2030 with a CAGR of 2.5% during the review period (2024-2030).
Published: 2024-12-26
Pages: 93
USD 4350.00 (Single User License)
Global Cardiopulmonary Support System Market Insights, Forecast to 2030
Valued at US$ 138 million in 2024, the global Cardiopulmonary Support System market is forecast to reach US$ 160 million by 2030, at a CAGR of 2.5% during the forecast period.
Published: 2024-12-26
Pages: 122
USD 4900.00 (Single User License)
Global Cardiopulmonary Support System Market Research Report 2024
The global market for Cardiopulmonary Support System was valued at US$ 135 million in the year 2023 and is projected to reach a revised size of US$ 160 million by 2030, growing at a CAGR of 2.5% during the forecast period.
Published: 2024-12-26
Pages: 74
USD 2900.00 (Single User License)